These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1128885)

  • 21. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International Symposium on Measles Immunization: summary and recommendations.
    Katz SL
    Pediatrics; 1983 Apr; 71(4):653-4. PubMed ID: 6835744
    [No Abstract]   [Full Text] [Related]  

  • 23. Guidelines for measles control in Canada.
    CMAJ; 1988 Mar; 138(6):527-9. PubMed ID: 3345478
    [No Abstract]   [Full Text] [Related]  

  • 24. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Single or double dose of vaccine needed for the eradication of measles in Spain?].
    Vitoria Miñana I; Morales Suárez-Varela M; Cotanda Gutiérrez P; Asensi Botet F
    An Esp Pediatr; 1993 Feb; 38(2):130-4. PubMed ID: 8439098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimum age for measles immunization.
    John TJ
    Indian Pediatr; 1982 May; 19(5):455-6. PubMed ID: 7141661
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serological evaluation of immunization against measles with 2 doses administered at 6 and 11 months of age: a prospective study].
    Pannuti CS; de Souza VA; Sato HK; Fink MC; Ribeiro MI; Hisi SK; Castelo A; de Mendonça JS
    Rev Inst Med Trop Sao Paulo; 1990; 32(6):450-5. PubMed ID: 2135492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statement on recommended use of measles vaccine in Canada.
    CMAJ; 1990 Aug; 143(4):287-9. PubMed ID: 2383849
    [No Abstract]   [Full Text] [Related]  

  • 31. Measles outbreak after a post-honeymoon period in Mongolia, 2001.
    Rentsen T; Enkhtuya B; Nymadawa P; Kobune F; Suzuki K; Yoshida H; Hachiya M
    Jpn J Infect Dis; 2007 Jul; 60(4):198-9. PubMed ID: 17642531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Guidelines for vaccination against measles in children].
    Avila-Figueroa C; Navarrete-Navarro S; Santos JI
    Bol Med Hosp Infant Mex; 1990 Jul; 47(7):528-33. PubMed ID: 2206422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination against measles. Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Third report to the Medical Research Council by the Measles Vaccines Committee.
    Practitioner; 1971 Apr; 206(234):458-66. PubMed ID: 4930718
    [No Abstract]   [Full Text] [Related]  

  • 34. [Measles immunization and its problems].
    Kökkaya A
    Mikrobiyol Bul; 1982 Jan; 16(1):66-70. PubMed ID: 7144618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles vaccination: revised recommendations for immunization.
    Reece SM
    Nurse Pract; 1990 Dec; 15(12):19-20, 23-4. PubMed ID: 2284058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Field evaluation of measles vaccine efficacy in Najafgarh zone of delhi.
    Sharma RS; Chawla U; Datta KK
    J Commun Dis; 1988 Mar; 20(1):38-43. PubMed ID: 3230287
    [No Abstract]   [Full Text] [Related]  

  • 37. Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule.
    Domínguez A; Torner N; Barrabeig I; Rovira A; Rius C; Cayla J; Plasencia E; Minguell S; Sala MR; Martínez A; Costa J; Mosquera M; Cabezas C;
    Clin Infect Dis; 2008 Nov; 47(9):1143-9. PubMed ID: 18823269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Measles vaccination of pre-school children: a detailed study of reaction frequency and side effects after immunization with vaccine of 3 different strengths].
    Böttiger M; Heller L; Kamensky P; Svanberg B
    Lakartidningen; 1974 Sep; 71(36):3270-4. PubMed ID: 4410083
    [No Abstract]   [Full Text] [Related]  

  • 39. [Recent deliberations on vaccination against measles in Denmark].
    Zoffmann H; Koch C
    Ugeskr Laeger; 1982 Jan; 144(3):137-41. PubMed ID: 7043842
    [No Abstract]   [Full Text] [Related]  

  • 40. Two-dose measles immunization as a strategy to eliminate measles in the Middle East and Israel.
    Belmaker I; Bazarsky E; Dukhan L; Shlomo C; Rager-Zisman B
    Isr Med Assoc J; 2008; 10(8-9):640-5. PubMed ID: 18847169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.